Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Atencion Primaria|December 23, 2008
[Influence of morbidity and the use of health resources in patients who require care for generalised anxiety disorder in the primary health care setting]Antoni Sicras-Mainar, Milagrosa Blanca-Tamayo, Ruth Navarro-Artieda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 30, 2019
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective StudyIrene Romera, Silvia Díaz, Antoni Sicras-Mainar, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 2, 2019
Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary diseaseAntoni Sicras Mainar, Alicia Huerta, Ruth Navarro Artieda, et al.
European Addiction Research|October 31, 2016
Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System PerspectiveSergio Cedillo, Antoni Sicras-Mainar, Carlos A Jiménez-Ruiz, et al.
Atencion Primaria|October 24, 2007
[Calculation of morbidity, use of resources and costs of patients treated with tiotropium bromide for COPD in a Spanish population]Antoni Sicras-Mainar, Soledad Velasco-Velasco, Josep Ramon Llopart-López, et al.
Arthritis Research & Therapy|April 16, 2009
Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness studyAntoni Sicras-Mainar, Javier Rejas, Ruth Navarro, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 6, 2018
Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalinAntoni Sicras-Mainar, Javier Rejas-Gutiérrez, María Pérez-Paramo, et al.
Current Medical Research and Opinion|November 2, 2010
Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequencesAntoni Sicras-Mainar, Ruth Navarro-Artieda, Milagrosa Blanca-Tamayo, et al.
Revista Espanola De Enfermedades Digestivas|November 23, 2020
Overall clinical and economic impact of non-alcoholic fatty liver diseaseAntoni Sicras-Mainar, Rocío Aller, Javier Crespo, et al.
Atencion Primaria|January 11, 2011
[Fixed drug combinations in hypertension: a budget impact analysis for the Spanish Health System on the marketing of a fixed combination of olmesartan/amlodipine]M Belén Ferro-Rey, Alex Roca-Cusachs, Antoni Sicras-Mainar, et al.
Pageof 12